|
|
|
| Investigation and analysis of children’s medication information in the drug instructions for intravenous drip medication in Maternal and Child Health Hospital of Tongling#br# |
| ZHENG Chao SUN Ji |
| Department of Pharmacy, Maternal and Child Health Hospital of Tongling, Anhui Province, Tongling 244000, China |
|
|
|
Abstract Objective To investigate the information labeling conditions of children’s medication in the instructions for intravenous drip medicines in Maternal and Child Health Hospital of Tongling (“our hospital” for short), and to provide a reference for standardizing the information on the instructions. Methods The instructions for intravenous infusion medicines used in our hospital from January to April 2021 was collected, the medication information for children mentioned in ten items such as “usage and dosage” “adverse reactions” and “children’s medications” in the instructions into an Excel table were listed, and statistical analysis to relevant content was carried on. Results The labeling rate of children’s medication information in 104 intravenous drip drug inserts was generally low; the labeling rate of children’s drug information in the foreign-funded drug manuals was generally higher than that of domestic drugs; the labeling rate of children’s medication information in western medicine instructions was generally higher than that of Chinese patent medicines; “children’s medication” item of medication information labeling was seriously missing; the instruction manual was not revised in time; among them, the conversion of children’s drug dosage in the antibacterial drug instructions was not standardized; there were differences in the usage and dosage of the three groups of foreign and domestic intravenous antibacterial drugs in the instructions for children. Conclusion There are many problems in the labeling of children’s medication information in the instructions for intravenous infusion drugs, which need to be further improved and should be paid attention by the relevant national departments.
|
|
|
|
|
|
[1] 刘宝生，周秀丽，宫凯凯.山东省8566例新的药品不良反应报告分析[J].中国药房，2021，4（32）：475-479.
[2] 陶柏成，薛进，周丽芳.注射剂说明书中儿童用药信息标注情况与儿童用药风险分析[J].儿科药学杂志，2020，26（7）：40-43.
[3] 江永贤，蒲欣瑜，陈文文，等.新生儿超说书用药现状分析与风险对策[J].中国药物警戒，2021，2（18）：164-169.
[4] 王业民，张永香，张卫国，等.271份注射用粉针剂药品说明书信息分析[J].西北药学杂志，2020，35（5）：772-778.
[5] 国家食品药品监督管理局.药品说明书和标签管理规定[S].2006-06-01.
[6] 国家食品药品监督管理局.关于印发化学药品和生物制品说明书规范细则的通知[S].2006-05-10.
[7] 国家食品药品监督管理局.关于印发中药、天然药物处方药说明书格式内容书写要求与撰写指导原则的通知[S].国食药监注〔2006〕283号.
[8] FDA. Pediatric Information Incorporated into Human Prescription Drug and Biological Product Labeling Guidance for Industry [EB/OL].（2019-03-27） [2021-06-16]. https://www.fda.gov/media/84949/download.
[9] EMA. Revision 1 - Frequently asked questions on SmPC paediatric information [EB/OL]. （2019-03-26）[2021-06-16]. https://www.ema.europa.eu/en/documents/other/frequently-asked-questions-smpc-paediatric-information_en.pdf.
[10] 张明，萧惠来.FDA对人用处方药和生物制品说明书儿科资料的要求[J].药物评价研究，2020，43（7）：1228-1232.
[11] 李亚昙，贾琳，滕亮.国内外儿科超说明书用药近况的系统评价[J].中国医院药学杂志，2016，36（23）：2114-2119.
[12] 闫聪聪，王晓玲，张胜男，等.国内8家儿童医院常用药品说明书中儿童用药信息的调查分析[J].中国药事，2021， 35（1）：10-15.
[13] 符海郯，程烨，张倩睿.90种中成药说明书中妊娠禁忌证及儿童用药标注情况调查分析[J].医药导报，2021， 40（1）：109-114.
[14] 陈莉，何娟，上官小芳，等.湖北省38425例儿童药品不良反应分析[J].医药导报，2020，39（10）：1362-1365.
[15] 聂晓璐，贾露露，彭晓霞，等.家庭药物储存及儿童用药行为现况研究[J].中华流行病学杂志，2016，37（7）：921-924.
[16] 魏婷，王晓玲，金彦，等.我国微生态制剂儿童用药信息的调查分析[J].中国药房，2019，30（22）：3155-3159.
[17] 国家卫生和计划生育委员会，国家发展和改革委员会，工业和信息化部，等.《关于保障儿童用药的若干意见》[S].国卫药政发〔2014〕29号.
[18] 吴娟，张顺国，黄诗颖，等.儿童药物临床试验的发展及现状[J].医药导报，2018，37（1）：74-77.
[19] 李丰杉，余勤.儿童用药研发及儿科临床试验的国际发展和国内现状[J].中国新药杂志，2020，29（17）：1933-1938.
[20] 王东东，闫荟羽，张杰，等.抗菌药物说明书中儿童用药信息调查分析[J].儿科药学杂志，2020，26（9）：45-48.
[21] 国家食品药品监督管理局药品评价中心.《药品不良反应信息通报》（第48期）[EB/OL].（2012-06-28）[2021-07-10].http://www.cdr-adr.org.cn/drug_1/aqjs_1/drug_ aqjs_xxtb/201206/t20120628_36843.html.
[22] 赵婷婷，赵建中，王海学.关于规范国内已上市药品说明书的几点思考[J].中国临床药理学杂志，2020，36（14）：2153-2155.
[23] 胡雪，赵爽，王相峰，等.止咳祛痰平喘类药品说明书中儿童用药标注统计分析[J].儿科药学杂志，2020，26（12）：49-51.
[24] 王卫平.儿科学[M].8版.北京：人民卫生出版社，2013：3-4．
[25] 鲍志伟，崔朝，马静，等.抗肿瘤药物说明书166份妊娠及哺乳期妇女用药标注情况分析[J].安徽医药，2021， 25（4）：842-845. |
|
|
|
